Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

National Institutes of Health at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

National Institutes of Health brings 16 presentations to ASH 2026 in New Orleans. Its program spans bone marrow failure, CAR T-cell therapy in young patients and rare immune and clotting disorders. It covers a sirolimus trial for relapse prevention in severe aplastic anemia and a bicistronic CD19 and CD22 CAR T-cell study.

OrganizationASH 2026 Attendance
Government & non-profit
US federal medical research agency that funds and conducts biomedical research through its institutes and centers.
Symposium
Fri Dec 11
7:00am–10:00am
From Controversies to Consensus in Paroxysmal Nocturnal Hemoglobinuria: Developing IPIG Guidelines
Expert consensus on paroxysmal nocturnal hemoglobinuria, debating disease types, anticoagulation, and breakthrough hemolysis on complement inhibitors.
Red cells · Patient care
Session
Sun Dec 13
8:00am–9:00am
ASH Poster Walk on New Developments in Targeted Therapies for Myeloid Malignancies Hosted by Blood Neoplasia
New targeted drugs for myeloid cancers, including menin inhibitors and approaches to gene-mutated acute myeloid leukemia.
Leukemias · New drugs

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at National Institutes of Health

Tell us what you sell and we’ll find the people at National Institutes of Health most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction